Substituted 2-arylbenzothiazoles as kinase inhibitors: Hit-to-lead optimization

被引：37
|
作者：
Tasler, Stefan [1 ]
Mueller, Oliver [1 ]
Wieber, Tanja [1 ]
Herz, Thomas [1 ]
Pegoraro, Stefano [1 ]
Saeb, Wael [1 ]
Lang, Martin [1 ]
Krauss, Rolf [1 ]
Totzke, Frank [2 ]
Zirrgiebel, Ute [2 ]
Ehlert, Jan E. [2 ]
Kubbutat, Michael H. G. [2 ]
Schaechtele, Christoph [2 ]
机构：
[1] 4SC AG, D-82152 Planegg Martinsried, Germany
[2] ProQinase GmbH, D-79106 Freiburg, Germany
来源：
BIOORGANIC & MEDICINAL CHEMISTRY | 2009年 / 17卷 / 18期
关键词：
Cancer; Protein kinase; vHTS; Multi-target approach; RECEPTOR TYROSINE KINASE; BREAST-CANCER CELLS; POTENT; IDENTIFICATION; DISCOVERY; THERAPY; COMPLEX; TARGETS; DESIGN; DOMAIN;
D O I：
10.1016/j.bmc.2009.07.047
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Based on an (aminoaryl)benzothiazole quinazoline hit structure for kinase inhibition, a systematic optimization program resulted in a lead structure allowing for inhibitory activities in cellular phosphorylation assays in the low nanomolar range. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码：6728 / 6737
页数：10
相关论文
共 50 条
  • [21] Hit-to-lead optimization of 1,4-dihydroindeno[1,2-c]pyrazoles as a novel class of KDR kinase inhibitors
    Dinges, Jurgen
    Akritopoulou-Zanze, Irini
    Arnold, Lee D.
    Barlozzari, Teresa
    Bousquet, Peter F.
    Cunha, George A.
    Ericsson, Anna M.
    Iwasaki, Nobuhiko
    Michaelides, Michael R.
    Ogawa, Nobuo
    Phelan, Kathleen M.
    Rafferty, Paul
    Sowin, Thomas J.
    Stewart, Kent D.
    Tokuyama, Ryukou
    Xia, Zhiren
    Zhang, Henry Q.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (16) : 4371 - 4375
  • [22] Thienopyrimidines as β3-adrenoceptor agonists: Hit-to-lead optimization
    Tasler, Stefan
    Baumgartner, Roland
    Ammendola, Astrid
    Schachtner, Josef
    Wieber, Tanja
    Blisse, Marcus
    Rath, Sandra
    Zaja, Mirko
    Klahn, Philipp
    Quotschalla, Udo
    Ney, Peter
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (20) : 6108 - 6115
  • [23] Hit-to-Lead Optimization of Benzoxazepinoindazoles As Human African Trypanosomiasis Therapeutics
    Klug, Dana M.
    Tschiegg, Laura
    Diaz, Rosario
    Rojas-Barros, Domingo
    Perez-Moreno, Guiomar
    Ceballos, Gloria
    Garcia-Hernandez, Raquel
    Santos Martinez-Martinez, Maria
    Manzano, Pilar
    Miguel Ruiz, Luis
    Caffrey, Conor R.
    Gamarro, Francisco
    Gonzalez Pacanowska, Dolores
    Ferrins, Lori
    Navarro, Miguel
    Pollastri, Michael P.
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (05) : 2527 - 2546
  • [24] Phenocopy - A Strategy to Qualify Chemical Compounds during Hit-to-Lead and/or Lead Optimization
    Baum, Patrick
    Schmid, Ramona
    Ittrich, Carina
    Rust, Werner
    Fundel-Clemens, Katrin
    Siewert, Susanne
    Baur, Martin
    Mara, Lisa
    Gruenbaum, Lore
    Heckel, Armin
    Eils, Roland
    Kontermann, Roland E.
    Roth, Gerald J.
    Gantner, Florian
    Schnapp, Andreas
    Park, John E.
    Weith, Andreas
    Quast, Karsten
    Mennerich, Detlev
    PLOS ONE, 2010, 5 (12): : 1 - 15
  • [25] Tracing Binding Modes in Hit-to-Lead Optimization: Chameleon-Like Poses of Aspartic Protease Inhibitors
    Kuhnert, Maren
    Koester, Helene
    Bartholomaeus, Ruben
    Park, Ah Young
    Shahim, Amir
    Heine, Andreas
    Steuber, Holger
    Klebe, Gerhard
    Diederich, Wibke E.
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2015, 54 (09) : 2849 - 2853
  • [26] Discovery of novel Rho kinase inhibitors: Hit generation and lead optimization
    Alexander, Brian G.
    Pireddu, Roberta
    Sun, Nan N.
    Yu, Huidong
    Forinash, Kara D.
    Martin, Matthew P.
    Schonbrunn, Ernst
    Guida, Wayne C.
    Sebti, Said M.
    Lawrence, Nicholas J.
    CANCER RESEARCH, 2011, 71
  • [27] Hit-to-lead optimization and kinase selectivity of imidazo[1,2-a]quinoxalin-4-amine derived JNK1 inhibitors
    Cociorva, Oana M.
    Li, Bei
    Nomanbhoy, Tyzoon
    Weissig, Helge
    Li, Qiang
    Nakamura, Kai
    Liyanage, Marek
    Zhang, Melissa C.
    Shih, Ann Y.
    Aban, Arwin
    Hu, Yi
    Cajica, Julia
    Lan Pham
    Kozarich, John W.
    Shreder, Kevin R.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
  • [28] Identification, characterization and initial hit-to-lead optimization of a series of 4-arylamino-3-pyridinecarbonitrile as protein kinase C theta (PKCθ) inhibitors
    Cole, Derek C.
    Asselin, Magda
    Brennan, Agnes
    Czerwinski, Robert
    Ellingboe, John W.
    Fitz, Lori
    Greco, Rita
    Huang, Xinyi
    Joseph-McCarthy, Diane
    Kelly, Michael F.
    Kirisits, Matthew
    Lee, Julie
    Li, Yuanhong
    Morgan, Paul
    Stock, Joseph R.
    Tsao, Desiree H. H.
    Wissner, Allan
    Yang, Xiaoke
    Chaudhary, Divya
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (19) : 5958 - 5963
  • [29] Hit-to-lead optimization of a 2-aminobenzimidazole series as new candidates for chagas disease
    de Oliveira Rezende Jr, Celso
    Martinez, Pablo David Grigol
    Ferreira, Rafael Augusto Alves
    Koovits, Paul John
    Soares, Bruna Miranda
    Ferreira, Leonardo L. G.
    Michelan-Duarte, Simone
    Chelucci, Rafael Consolin
    Andricopulo, Adriano D.
    Matheeussen, An
    Van Pelt, Natascha
    Caljon, Guy
    Maes, Louis
    Campbell, Simon
    Kratz, Jadel M.
    Mowbray, Charles E.
    Dias, Luiz Carlos
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 246
  • [30] Hit-to-lead optimization and kinase selectivity of imidazo[1,2-a]quinoxalin-4-amine derived JNK1 inhibitors
    Li, Bei
    Cociorva, Oana M.
    Nomanbhoy, Tyzoon
    Weissig, Helge
    Li, Qiang
    Nakamura, Kai
    Liyanage, Marek
    Zhang, Melissa C.
    Shih, Ann Y.
    Aban, Arwin
    Hu, Yi
    Cajica, Julia
    Pham, Lan
    Kozarich, John W.
    Shreder, Kevin R.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (18) : 5217 - 5222
12345